Clinical Trials
3
Active:2
Completed:1
Trial Phases
2 Phases
Phase 1:2
Phase 4:1
Drug Approvals
3
SFDA:2
EMA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 4
1 (33.3%)MEthylene Blue In Patients With Acquired Methemoglobinemia
- First Posted Date
- 2018-01-10
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- Provepharm SAS
- Target Recruit Count
- 7
- Registration Number
- NCT03395223
- Locations
- 🇫🇷
Hôpital Lariboisière, Paris, France
News
No news found